Drugs / MRKAd5 HIV-1 gag/pol/nef
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00350623 | Oct 2006 → May 2008 | HIV infectious disease | Merck Sharp & Dohme LLC | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MRKAd5 HIV-1 gag/pol/nef | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00350623 ↗ |
| Modality | Vaccine | “HIV vaccine” NCT00350623 ↗ |
| Route | Intramuscular | “intramuscular injections” NCT00350623 ↗ |